FI913554A - Förfarande för framställning av en stabiliserad farmaceutisk komposition - Google Patents

Förfarande för framställning av en stabiliserad farmaceutisk komposition Download PDF

Info

Publication number
FI913554A
FI913554A FI913554A FI913554A FI913554A FI 913554 A FI913554 A FI 913554A FI 913554 A FI913554 A FI 913554A FI 913554 A FI913554 A FI 913554A FI 913554 A FI913554 A FI 913554A
Authority
FI
Finland
Prior art keywords
preparing
pharmaceutical composition
stabilized pharmaceutical
stabilized
composition
Prior art date
Application number
FI913554A
Other languages
English (en)
Finnish (fi)
Other versions
FI98127C (sv
FI98127B (sv
FI913554A0 (sv
Inventor
Bruce Allan Ross
Richard Victor Vivilecchia
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI913554A0 publication Critical patent/FI913554A0/sv
Publication of FI913554A publication Critical patent/FI913554A/sv
Application granted granted Critical
Publication of FI98127B publication Critical patent/FI98127B/sv
Publication of FI98127C publication Critical patent/FI98127C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI913554A 1990-07-25 1991-07-24 Förfarande för framställning av en stabiliserad farmaceutisk komposition FI98127C (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55723490A 1990-07-25 1990-07-25

Publications (4)

Publication Number Publication Date
FI913554A0 FI913554A0 (sv) 1991-07-24
FI913554A true FI913554A (sv) 1992-01-26
FI98127B FI98127B (sv) 1997-01-15
FI98127C FI98127C (sv) 1997-04-25

Family

ID=24224569

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913554A FI98127C (sv) 1990-07-25 1991-07-24 Förfarande för framställning av en stabiliserad farmaceutisk komposition

Country Status (30)

Country Link
EP (1) EP0468929B1 (sv)
JP (1) JP2502849B2 (sv)
KR (1) KR100227156B1 (sv)
AT (1) AT400519B (sv)
AU (1) AU639354B2 (sv)
CA (1) CA2047802C (sv)
CH (1) CH683150A5 (sv)
CZ (1) CZ280184B6 (sv)
DE (1) DE4124409B4 (sv)
DK (1) DK0468929T3 (sv)
ES (1) ES2061218T3 (sv)
FI (1) FI98127C (sv)
GB (1) GB2246296B (sv)
HU (1) HU222489B1 (sv)
IE (1) IE66184B1 (sv)
IL (1) IL98934A (sv)
IT (1) IT1290797B1 (sv)
LU (1) LU87980A1 (sv)
MX (1) MX9100357A (sv)
MY (1) MY107183A (sv)
NO (1) NO912872D0 (sv)
NZ (1) NZ239078A (sv)
PL (1) PL167712B1 (sv)
PT (1) PT98417B (sv)
RU (1) RU2075310C1 (sv)
SA (1) SA92130106B1 (sv)
SK (1) SK278563B6 (sv)
TW (1) TW212757B (sv)
UA (1) UA26064A1 (sv)
ZA (1) ZA915861B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2942495A (en) * 1994-07-13 1996-02-16 Lek Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
HU222497B1 (hu) * 1996-12-18 2003-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására
CN1144598C (zh) * 1998-06-05 2004-04-07 沃尼尔·朗伯公司 利用氧化镁稳定的含ace抑制剂的组合物
KR100483080B1 (ko) * 2001-09-21 2005-04-14 한인규 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제
US6462022B1 (en) † 2001-09-24 2002-10-08 Astrazeneca Ab Lisinopril compositions having large-particle DCPD
ES2283774T3 (es) * 2002-01-15 2007-11-01 Actavis Group Hf. Formulaciones de quinapril e inhibidores de la eca relacionados.
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
CN110662534A (zh) 2017-05-31 2020-01-07 勃林格殷格翰国际有限公司 包含(e)-4-(2-(氨基甲基)-3-氟烯丙基氧基)-n-叔丁基苯甲酰胺的药物组合物和药物剂型，其制备方法、治疗方法及用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895027A (en) * 1959-08-03 1962-04-26 Bristol Myers Co Therapeutic tetracycline compositions
GB1437788A (en) * 1973-01-31 1976-06-03 Gist Brocades Nv Therapeutic compositions
HU173823B (hu) * 1975-07-25 1979-08-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija stabil'nogo lechebnogo preparata dlja oral'noj dozirovki, kotoryj soderzhit proizvodnyj gomopirimidazola
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
US4575539A (en) * 1985-06-03 1986-03-11 E. R. Squibb & Sons, Inc. Drug delivery systems including novel interpenetrating polymer networks and method
US4900559A (en) * 1985-12-12 1990-02-13 Briston-Myers Company Stabilized enteric coated aspirin granules and process of preparation
DE3627613A1 (de) * 1986-08-14 1988-02-18 Merck Patent Gmbh Pharmazeutische zubereitung
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
AU608891B2 (en) * 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US4912096A (en) * 1989-06-26 1990-03-27 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing an ace inhibitor

Also Published As

Publication number Publication date
IT1290797B1 (it) 1998-12-11
KR100227156B1 (ko) 1999-10-15
EP0468929B1 (en) 1994-09-28
DK0468929T3 (da) 1994-12-27
IL98934A (en) 1996-07-23
PT98417A (pt) 1992-06-30
PL291219A1 (en) 1992-08-24
CS230991A3 (en) 1992-04-15
ES2061218T3 (es) 1994-12-01
FI98127C (sv) 1997-04-25
SA92130106B1 (ar) 2005-10-16
PL167712B1 (en) 1995-10-31
DE4124409A1 (de) 1992-01-30
EP0468929A2 (en) 1992-01-29
RU2075310C1 (ru) 1997-03-20
CA2047802A1 (en) 1992-01-26
ATA147691A (de) 1995-06-15
CZ280184B6 (cs) 1995-11-15
ITRM910554A1 (it) 1993-01-23
LU87980A1 (fr) 1993-02-15
IL98934A0 (en) 1992-07-15
UA26064A1 (uk) 1999-04-30
GB9115893D0 (en) 1991-09-04
TW212757B (sv) 1993-09-11
NZ239078A (en) 1993-10-26
HUT59819A (en) 1992-07-28
KR920002146A (ko) 1992-02-28
ZA915861B (en) 1993-03-31
FI98127B (sv) 1997-01-15
AU639354B2 (en) 1993-07-22
EP0468929A3 (en) 1992-02-19
SK278563B6 (en) 1997-10-08
DE4124409B4 (de) 2004-11-18
MX9100357A (es) 1992-02-28
AU8128691A (en) 1992-01-30
AT400519B (de) 1996-01-25
FI913554A0 (sv) 1991-07-24
CA2047802C (en) 2003-05-06
HU222489B1 (hu) 2003-07-28
HU9102385D0 (en) 1991-12-30
MY107183A (en) 1995-09-30
GB2246296A (en) 1992-01-29
GB2246296B (en) 1994-04-06
IE912608A1 (en) 1992-01-29
IE66184B1 (en) 1995-12-13
NO912872D0 (no) 1991-07-23
ITRM910554A0 (it) 1991-07-23
PT98417B (pt) 1999-01-29
CH683150A5 (de) 1994-01-31
JP2502849B2 (ja) 1996-05-29
JPH04253923A (ja) 1992-09-09

Similar Documents

Publication Publication Date Title
FI20000084A (sv) Förfarande för framställning av en antifungal farmaceutisk komposition
FI894342A (sv) Förfarande för framställning av en cyklosporin innehållande farmaceutisk sammansättning
FI101676B1 (sv) Förbättrat förfarande för framställning av en stabil mikrosfärkomposition
FI98192B (sv) Förfarande för framställning av en näringskomposition
FI892640A0 (sv) Förfarande för framställning av en piperidinoalkanol-ibuprofenkomposition innehållande farmaceutisk komposition
FI102458B (sv) Förfarande för framställning av en topikal farmaceutisk sammansättning
FI901787A0 (sv) Förfarande för framställning av en läkemedel avgivande komposition
FI104149B1 (sv) Förfarande för framställning av fördröjt frigörande blandningar
FI900604A0 (sv) Förfarande för framställning av en farmaceutisk sammansättning innehållande cyklosporin
FI885884A (sv) Förfarande för framställning av en långsamt frigörande farmaceutisk komposition
FI98196B (sv) Förfarande för framställning av en farmaceutisk beredning omfattande en mikroemulsion
FI96029B (sv) Analogiförfarande för framställning av ett som läkemedel användbart pyridinderivat
FI98924B (sv) Förfarande för framställning av ett pigment
FI102391B1 (sv) Förfarande för framställning av en cellulosaformkropp
FI883261A (sv) Förfarande för framställning av en farmaceutisk komposition innefattande en somatostatinanalog
FI913554A0 (sv) Förfarande för framställning av en stabiliserad farmaceutisk komposition
FI902316A0 (sv) Förfarande för framställning av terapeutiskt verkande substituerade dihydropyrrolizinföreningar
FI98459B (sv) Förfarande för framställning av terapeutiskt användbara 5-etano-2,3,4,5-1H-2-bentsazsepin
PT87672A (pt) Process for preparing a pharmaceutical composition
FI910967A0 (sv) Förfarande för framställning av bisfenol A
FI101600B1 (sv) Förfarande för framställning av en farmaceutiskt formulation
FI942797A0 (sv) Förfarande för framställning av en karbonatkomposition
FI920675A (sv) Ett nytt förfarande för framställning av 9-amino-1,2,3,4-tetrahydroakridiner
FI944460A0 (sv) Förfarande för framställning av ett läkemedelspreparat
GB9123241D0 (en) A process for preparing a pharmaceutical composition

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MA Patent expired